Suivre
Arturo Avalos-Fuentes
Arturo Avalos-Fuentes
Adresse e-mail validée de cinvestav.mx
Titre
Citée par
Citée par
Année
A reevaluation of chitosan-decorated nanoparticles to cross the blood-brain barrier
H Cortés, S Alcalá-Alcalá, IH Caballero-Florán, SA Bernal-Chávez, ...
Membranes 10 (9), 212, 2020
662020
D3 dopamine receptors interact with dopamine D1 but not D4 receptors in the GABAergic terminals of the SNr of the rat
R Cruz-Trujillo, A Avalos-Fuentes, C Rangel-Barajas, F Paz-Bermúdez, ...
Neuropharmacology 67, 370-378, 2013
592013
Presynaptic cannabinoid CB2 receptors modulate [3H]‐Glutamate release at subthalamo‐nigral terminals of the rat
R Sánchez‐Zavaleta, H Cortés, JA Avalos‐Fuentes, U García, ...
Synapse 72 (11), e22061, 2018
382018
Presynaptic CaMKIIα modulates dopamine D3 receptor activation in striatonigral terminals of the rat brain in a Ca2+ dependent manner
A Avalos-Fuentes, S Loya-López, A Flores-Pérez, S Recillas-Morales, ...
Neuropharmacology 71, 273-281, 2013
322013
Presynaptic dopamine D2 receptors modulate [3H] GABA release at StriatoPallidal terminals via activation of PLC→ IP3→ calcineurin and inhibition of AC→ cAMP→ PKA signaling …
R Jijón-Lorenzo, IH Caballero-Florán, S Recillas-Morales, H Cortés, ...
Neuroscience 372, 74-86, 2018
222018
Dopaminergic denervation switches dopamine D3 receptor signaling and disrupts its Ca2+ dependent modulation by CaMKII and calmodulin in striatonigral projections of the rat
A Avalos-Fuentes, S Albarrán-Bravo, S Loya-Lopéz, H Cortés, ...
Neurobiology of Disease 74, 336-346, 2015
212015
Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma
MG Chávez-López, V Zúñiga-García, JI Perez-Carreon, A Avalos-Fuentes, ...
Biologics: Targets and Therapy, 139-148, 2016
182016
Repositioning of drugs for Parkinson’s disease and pharmaceutical nanotechnology tools for their optimization
H Hernández-Parra, H Cortés, JA Avalos-Fuentes, M Del Prado-Audelo, ...
Journal of Nanobiotechnology 20 (1), 413, 2022
172022
D2 autoreceptor switches CB2 receptor effects on [3H]‐dopamine release in the striatum
G López‐Ramírez, R Sánchez‐Zavaleta, A Ávalos‐Fuentes, J Jose Sierra, ...
Synapse 74 (3), e22139, 2020
172020
Nanotechnology as potential tool for siRNA delivery in Parkinson's disease
H Cortes, S Alcala-Alcala, A Avalos-Fuentes, N Mendoza-Munoz, ...
Current drug targets 18 (16), 1866-1879, 2017
162017
Eag1 gene and protein expression in human retinoblastoma tumors and its regulation by pRb in HeLa cells
MG Chávez-López, V Zúñiga-García, BE Castro-Magdonel, E Vera, ...
Genes 11 (2), 119, 2020
142020
Presynaptic control of [3H]-glutamate release by dopamine receptor subtypes in the rat substantia nigra. Central role of D1 and D3 receptors
LJ Briones-Lizardi, H Cortés, JA Avalos-Fuentes, FJ Paz-Bermúdez, ...
Neuroscience 406, 563-579, 2019
142019
Cdk5 phosphorylates CaV1. 3 channels and regulates GABAA-mediated miniature inhibitory post-synaptic currents in striato-nigral terminals
S Loya-López, A Sandoval, R González-Ramírez, A Calderón-Rivera, ...
Biochemical and Biophysical Research Communications 524 (1), 255-261, 2020
102020
CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´ s disease
LF Narváez-Pérez, F Paz-Bermúdez, JA Avalos-Fuentes, ...
Gene Therapy 31 (1), 31-44, 2024
92024
Severity of dyskinesia and D3R signaling changes induced by L-DOPA treatment of hemiparkinsonian rats are features inherent to the treated subjects
S Albarrán-Bravo, JA Ávalos-Fuentes, H Cortés, M Rodriguez-Sánchez, ...
Biomolecules 9 (9), 431, 2019
82019
Blockade of intranigral and systemic D3 receptors stimulates motor activity in the rat promoting a reciprocal interaction among glutamate, dopamine, and GABA
M Rodríguez-Sánchez, RE Escartín-Pérez, G Leyva-Gómez, ...
Biomolecules 9 (10), 511, 2019
72019
Presynaptic nigral GPR55 receptors stimulate [3H]‐GABA release through [3H]‐cAMP production and PKA activation and promote motor behavior
R Sánchez‐Zavaleta, JA Ávalos‐Fuentes, AV González‐Hernández, ...
Synapse 76 (11-12), e22246, 2022
62022
Dopamine D4 receptor modulates inhibitory transmission in pallido‐pallidal terminals and regulates motor behavior
I Conde Rojas, J Acosta‐García, RN Caballero‐Florán, R Jijón‐Lorenzo, ...
European Journal of Neuroscience 52 (11), 4563-4585, 2020
62020
Coexistence of D3R typical and atypical signaling in striatonigral neurons during dopaminergic denervation. Correlation with D3nf expression changes
B Campos Campos, A Ávalos‐Fuentes, C Piña Leyva, ...
Synapse 74 (8), e22152, 2020
52020
Dopamine D3 receptor modulates D2 receptor effects on cAMP and GABA release at striatopallidal terminals—Modulation by the Ca2+–Calmodulin–CaMKII system
FS Villalobos‐Escobedo, R Jijón‐Lorenzo, JA Avalos‐Fuentes, ...
European Journal of Neuroscience 59 (7), 1441-1459, 2024
12024
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20